Boosters Won't Make It To Everyone For Now, But Vaccines For Young Children Are Coming

1200w,https://media.npr.org/assets/img/2021/09/21/gettyimages-1234851126-a0805730f84074c81f4c27c53b57d4d99b9aa419-s1600-c85.jpg 1600w,https://media.npr.org/assets/img/2021/09/21/gettyimages-1234851126-a0805730f84074c81f4c27c53b57d4d99b9aa419-s1800-c85.jpg 1800w" sizes="(min-width: 1300px) 763px, (min-width: 1025px) calc(100vw - 496px), (min-width: 768px) calc(100vw - 171px), calc(100vw - 30px)" type="image/jpeg"/>

The FDA Advisory Committee decided not to approve boosters for people sixteen and up. Instead, they made a recommendation for those 65 and up, or younger people at high risk to get a booster shot right now from Pfizer-Biontech.

In the meantime, boosters from Moderna and Johnson & Johnson are going through their own approval process.

Dr. Anthony Fauci told NPR that could happen in less than a month.

While the rest of the American population awaits boosters, vaccinations for children between 5 and 11 years old have are safe and effective according to Pfizer.

NPR's Allison Aubrey has been reporting on what has to happen first before we start seeing kids get vaccinated.

In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.

Email us at This email address is being protected from spambots. You need JavaScript enabled to view it..

This episode was produced by Lee Hale. It was edited by Brianna Scott and Fatma Tanis. Our executive producer is Cara Tallo.